PAPER Taylor J
SEARCH RESULTS
331386 RESULTS
PAPER Lovestone S, Smith U
Advanced glycation end products, dementia, and diabetes.
Proc Natl Acad Sci U S A. 2014 Apr 1;111(13):4743-4. Epub 2014 Mar 25 PubMed: 24707042PAPER Miller-Fleming L, Antas P, Pais TF, Smalley JL, Giorgini F, Outeiro TF
Yeast DJ-1 superfamily members are required for diauxic-shift reprogramming and cell survival in stationary phase.
Proc Natl Acad Sci U S A. 2014 May 13;111(19):7012-7. Epub 2014 Apr 2 PubMed: 24706893PAPER Bhat KP, Yan S, Wang CE, Li S, Li XJ
Differential ubiquitination and degradation of huntingtin fragments modulated by ubiquitin-protein ligase E3A.
Proc Natl Acad Sci U S A. 2014 Apr 15;111(15):5706-11. Epub 2014 Mar 31 PubMed: 24706802PAPER Yu A, Shibata Y, Shah B, Calamini B, Lo DC, Morimoto RI
Protein aggregation can inhibit clathrin-mediated endocytosis by chaperone competition.
Proc Natl Acad Sci U S A. 2014 Apr 15;111(15):E1481-90. Epub 2014 Apr 1 PubMed: 24706768PAPER Welmer AK, Rizzuto D, Qiu C, Caracciolo B, Laukka EJ
Walking Speed, Processing Speed, and Dementia: A Population-Based Longitudinal Study.
J Gerontol A Biol Sci Med Sci. 2014 Apr 4; PubMed: 24706441PAPER Yamanaka T, Wong HK, Tosaki A, Bauer PO, Wada K, Kurosawa M, Shimogori T, Hattori N, Nukina N
Large-scale RNA interference screening in mammalian cells identifies novel regulators of mutant huntingtin aggregation.
PLoS One. 2014;9(4):e93891. Epub 2014 Apr 4 PubMed: 24705917PAPER Bhidayasiri R, Jitkritsadakul O, Colosimo C
Nocturnal manifestations of atypical parkinsonian disorders.
J Parkinsons Dis. 2014;4(2):223-36. PubMed: 24705593PAPER
Chapter 9. Dementia.
Hypertens Res. 2014 Apr;37(4) PubMed: 24705430PAPER de Hoyos-Alonso MC, Tapias-Merino E, Meseguer Barros CM, Sánchez-Martínez M, Otero A
Consumption trends for specific drugs used to treat dementia in the region of Madrid (Spain) from 2002 to 2012.
Neurologia. 2014 Apr 3; PubMed: 24704249PAPER Chen S, Gao S, Cheng D, Huang J
The characterization and comparison of amyloidogenic segments and non-amyloidogenic segments shed light on amyloid formation.
Biochem Biophys Res Commun. 2014 May 2;447(2):255-62. Epub 2014 Apr 1 PubMed: 24704202PAPER Lee HM, Kwon KY, Kim MJ, Jang JW, Suh SI, Koh SB, Kim JH
Subcortical grey matter changes in untreated, early stage Parkinson's disease without dementia.
Parkinsonism Relat Disord. 2014 Jun;20(6):622-6. Epub 2014 Mar 20 PubMed: 24703894PAPER Raskind MA, Wang LY
Antipsychotic drugs for psychosis and agitation in dementia: efficacy, safety, and a possible noradrenergic mechanism of action.
Int Psychogeriatr. 2014 Jun;26(6):879-83. Epub 2014 Apr 4 PubMed: 24703502PAPER Camilleri A, Vassallo N
The Centrality of Mitochondria in the Pathogenesis and Treatment of Parkinson's Disease.
CNS Neurosci Ther. 2014 Apr 7; PubMed: 24703487PAPER Chamorro A, Amaro S, Castellanos M, Segura T, Arenillas J, Martí-Fábregas J, Gállego J, Krupinski J, Gomis M, Cánovas D, Carné X, Deulofeu R, Román LS, Oleaga L, Torres F, Planas AM, URICO-ICTUS Investigators
Safety and efficacy of uric acid in patients with acute stroke (URICO-ICTUS): a randomised, double-blind phase 2b/3 trial.
Lancet Neurol. 2014 May;13(5):453-60. Epub 2014 Apr 2 PubMed: 24703208Current Filters
No filters selected